SNHG20 has been reported to be upregulated in serous epithelial ovarian cancer and induce the expression of E-cadherin by activating the Wnt/β-catenin pathway, subsequently promoting the proliferation, migration, and EMT ability of ovarian cancer cells.73 Here, SNHG20 is linked to ovarian carcinoma.